Sep 3, 2026 3-5pm ET
Thursday on The Robert Scott Bell Show:
Hour 1
Special Guest: Jonathan Emord
For the past 37 years, Jonathan W. Emord has litigated against the federal bureaucracy, winning over and over again. Ron Paul calls Jonathan “an expert in constitutional theory and history” and “an expert litigator with a long string of legal victories over the federal bureaucracy.” George Noory calls him “a Knight in Shining Armor” and “a warrior out to save our rights.” Congressmen Dan Burton and John Doolittle describe him as “an intellectual warrior for the rights and freedoms of people in America.” Jonathan has a unique, detailed knowledge of the federal bureaucracy, the deep state. He knows how to defeat it. Jonathan graduated from the University of Illinois (BA, political science and history, 1982) and DePaul University College of Law (JD, 1985). He served as an attorney in the Federal Communications Commission during the Reagan administration. A leading constitutional law and litigation expert, he is the author of five critically acclaimed books. He has won more cases against the Food and Drug Administration in federal court than any other attorney in American history, earning him the nickname “FDA Dragon Slayer.” He is a columnist for Townhall.com, PJ Media.com, Americangreatness.com, and the U.S.A. Today Magazine. He frequently appears on national radio and television programs. He is married to Sheryl Emord, and they have two children, twins Justice and Angelica. They reside in Clifton,
We Haven’t Yet Seen Accountability for COVID-Era Crimes — But Let’s Not Forget How Far We’ve Come Mary Holland, J.D., CEO of Children’s Health Defense, writes from remarks at Brownstone Institute’s Aug. 29, 2026, Polyface Farm conference that there has been no real accountability for COVID-era policies she says shredded First Amendment religion, speech, press, assembly, and petition rights through church closures, deplatforming, lockdowns, ignored court petitions, and wealth transfers, despite no pandemic exception in the Constitution, while Brownstone’s book “The Covid Response at Five Years” records a failure to reckon. She lists developments unthinkable in 2021: Robert F. Kennedy Jr. as HHS secretary with Jay Bhattacharya and Martin Kulldorff, Anthony Fauci held in Senate criminal contempt with diaries public, David Morens awaiting sentencing after a plea and implicating Peter Daszak, Vincent Munster facing sanctions over more than 100 mpox samples and gain-of-function work, Poul Thorsen arrested for CDC-related money laundering and wire fraud, Epstein files released, a presidential executive order on the childhood vaccine schedule and parental autonomy, and a WHO public-health treaty she says is in tatters. She argues courts follow culture, citing Judge Terry Doughty on Missouri v. Biden as a massive free-speech attack, CHD’s Kennedy v. Biden settlement with the Trump administration, two CHD preliminary injunctions against California medical-speech rules including after Chiles v. Salazar, Mahmoud v. Taylor on parental religious opt-outs, and Miller v. McDonald, the New York Amish vaccine-mandate case the Supreme Court sent back and that she expects the Court to take in October, with Lawrence Gostin predicting reversal if heard. She notes Meryl Nass’s Maine board victory, Pennsylvania’s measles-death narrative challenged by Lancaster officials, and next-five-year goals including PREP Act review, a nationwide religious exemption, schedule revision, injury compensation, and limits on bioweapons research, plus comments on the Aug. 10 executive order and CHD’s Sept. 17 D.C. conference.
The “Common Good” Is Not a Blank Check for Government Vance Ginn, Ph.D., president of Ginn Economic Consulting, argues in an Aug. 30, 2026, Let People Prosper essay that there is no single objective “common good” civil government can identify and coerce onto everyone, even though he affirms objective truth, God, virtue, faith, family, honesty, responsibility, and service. He wrote on X that common good is subjective because people differ, that government may consider shared interests but should not legislate or force one vision, and that the Founders built limited powers, federalism, property rights, religious liberty, and civil society to prevent a blank check. Critics citing Scripture, Aristotle, Aquinas, natural law, and Founding language of public good and general welfare, he says, miss jurisdiction: families, churches, communities, markets, and the state have different roles, and Romans 13 legitimizes civil authority without making government society’s moral manager. He applies James Buchanan’s public-choice “politics without romance” and Milton Friedman’s line-drawing question to Marco Rubio’s “common-good capitalism,” warning that moving choices from markets to officials does not turn self-interest into public interest and that “good for society” can justify managing almost all of life. The closest political common good, he writes, is liberty under equal rights, which lets Christians and others worship and raise families, entrepreneurs build firms, and churches teach without permission, while government still punishes murder, theft, and fraud and provides courts, defense, policing, and equal rights. Madison’s Federalist Nos. 10 and 51 treat factions and the need for government to control itself through enumerated powers and separation of powers. Exercise, charity, churchgoing, stable families, and saving are good, he says, but that does not authorize compulsion, and civilization’s goods largely arise outside the state. His bottom line is to protect life, liberty, property, contracts, and equal rights, constrain power, and let free people pursue the good as they understand it.
My Adverse Drug Reaction—and the Healthcare Lesson We Can’t Ignore Rob Verkerk, PhD, ANH founder and ANH-USA executive and scientific director, writes in an Aug. 28, 2026, piece adapted from a longer ANH International account that after more than 30 years avoiding prescriptions following multiple chemical sensitivity and a serious Lariam reaction in his twenties, he started allopurinol before planned foot surgery and developed a suspected serious hypersensitivity reaction within days. A 1995 motorcycle injury in Malaysia left later inflammation, imaging of a protective mass and apparent urate crystals, and a surgeon recommended six months of the uric-acid-lowering drug despite no gout history. Six days in, while driving, intense multi-muscle cramps began, then rashes, skin sensitivity, numbness, and neuropathic symptoms in arms, hands, and one leg, with night pain eased only by walking. He stopped the drug, researched with support from a French medical center, and notes allopurinol hypersensitivity syndrome is estimated at about one in 1,000 users with 20–25 percent mortality. With ANH-USA board member Nasha Winters, ND, he pursued kidney, liver, muscle, and nerve testing plus rest, hydration, nutrition, and natural compounds, and neuropathic numbness has been slowest to improve. He asks why his sensitivity history, leaflet warnings, biochemical terrain, baseline labs, lower starting doses, titration, and monitoring were not emphasized, citing FDA labeling of sometimes fatal reactions and Arthritis Foundation gout guidance that calls for uric acid, blood counts, liver and kidney tests and gradual titration. He argues “known” side effects are not trivial, that surgery and imaging remain needed for structural damage, and that connected care should combine conventional tools with nutritional and natural medicine, patient partnership, and MedWatch reporting because clinicians are not required to file.
Is Your Pet Being Exploited to Aid Pharma Profits?An Aug. 28, 2026, Alliance for Natural Health USA article adapted by Mike Ames-Sikora from Melissa Smith of ANH International argues that companion animals and livestock are developing human-like chronic disease as health care shifts toward drugs and biotech while nutrition, exercise, and stress recede. It cites dogs with rising obesity, type 2 diabetes, cardiovascular disease, and cancer, cats on thyroid drugs and insulin, dairy cows with more metabolic disorders, and Loyal, a San Francisco startup approaching a first-in-class dog longevity drug. A late-2025 peer-reviewed study, it says, documented a global rise in non-communicable disease in pets, livestock, and wildlife under human care, tied to ultra-processed diets, inactivity, pollutants, chronic stress, selective breeding for commercial traits, and precision-fermented ingredients entering animal feed. The piece warns self-amplifying RNA vaccines, already in use in animals, contain alphavirus-derived replication machinery that prolongs antigen production from small doses and raise unanswered questions on biodistribution, persistence, reproductive transfer, and food-chain exposure, while withdrawal rules were built for conventional drugs and veterinary pathways are faster than human ones, scaling platforms without labeling or long-term post-market evidence. It frames WHO’s One Health model as linking human, animal, and environmental health to pandemic preparedness and pharmaceutical management, treating animals as disease reservoirs and emphasizing surveillance and shots over industrial farming, toxicity, biodiversity loss, and habitat destruction. ANH’s alternative is species-appropriate nutrition, less ultra-processing, movement, lower toxins, less stress, genetic resilience, and better livestock crowding, confinement, and feed, arguing prevention is less profitable than lifelong treatment and that animal medicalization previews human health defined as continuous technological control.
How Neoliberals Fueled the Rise of Socialism Connor O’Keeffe writes on Sept. 2, 2026, that Washington’s alarm at American politicians who accept the socialist label is justified because socialism would politicize life and turn production into a zero-sum lobbying fight, but that neoliberal and neoconservative elites should not be surprised, because they defined a highly interventionist, inflationary, crony system as free-market capitalism. Citing Gabriel Kolko, Murray Rothbard, and Patrick Newman, he says the modern centralized state grew in the Progressive Era from well-connected business interests, not a public revolt against laissez-faire, and that crony redistribution is unstable, requiring new justifications after wars, credit distortions, and crises that Robert Higgs-style “crisis and Leviathan” dynamics then enlarge. He traces the 1980s Washington consensus to 1970s stagflation from Fed money printing for Vietnam and the Great Society, Bretton Woods collapse, OPEC shocks, Nixon controls, and New Left decline, with Milton Friedman’s monetarism and media style aiding Carter-era railroad, airline, and trucking deregulation later credited to Reagan. Rothbard, he notes, found 1981 tax cuts offset by same-year and later increases while spending rose, so the “Reagan revolution” accelerated intervention under free-market talk. The Friedmanites’ lasting win was monetary: a fiat, activist central bank, including Friedman and Anna Schwartz’s claim that the Depression reflected too little Fed printing. After 1980 the Fed financed hawkish policy and, under Alan Greenspan, easy money, cheap credit, and bailouts that made Wall Street the economy’s nerve center and stocks the gauge of strength. That financialized brand, O’Keeffe argues, supercharged Progressive-Era rackets while teaching the public that crises mean government is not involved enough, opening the door to democratic-socialist arguments.
The Philosophical Contradictions of Democratic Socialism Ruel Domi writes on Sept. 1, 2026, that the Democratic Socialists of America’s midterm platform, including abolition of the presidency, Supreme Court, and Senate plus open borders and nationalization of major firms, is internally incoherent even though it promises to join democracy with economic equality. He defines socialism as worker ownership of the means of production rooted in Marxist class conflict and the Manifesto’s path to a classless, stateless communism run through socialism, and says historical attempts produced state control via expropriation and persecution rather than worker control. Contemporary DSA figures reject Leninist, Stalinist, and Maoist one-party rule and seek democratic public ownership, he grants, but if socialism requires taking private property and economic rights it cannot be liberal democracy, which rests on property, speech, and conscience voting, so one cannot fully have both. He ties Lenin’s “dictatorship of the proletariat” as a centralized step toward communist utopia and argues that a model requiring such dictatorship is undemocratic by definition. Nordic and Western European systems, he says, are social democracies or welfare capitalism, not worker-owned planned economies, citing Danish Foreign Minister Lars Løkke Rasmussen that Denmark is a market economy, supply-and-demand pricing, high consumption and progressive taxes, resource management such as Norwegian oil funds, New Deal-style Keynesian redistribution inside capitalism, and Heritage and Tax Foundation findings that Scandinavia often scores higher economic freedom and lower corporate taxes than the United States. UK 1960s nationalizations preceded Thatcher’s liberalization, wealth taxes risk capital flight, and majority demands to nationalize firms or assign healthcare do not override constitutional limits on majority tyranny. Inequality and affordability deserve debate, he concludes, but undemocratic means cannot save democracy, so democratic socialism is a contradiction in terms.Hour 2
Special Guest Dr. Robert Malone
Robert W. Malone, MD, MS, author of Homesteading for Health, is an internationally recognized virologist and immunologist, clinical research and regulatory affairs expert, US federal contract proposal and project manager, and the original inventor of mRNA delivery and vaccination as a technology, DNA vaccination, and multiple non-viral DNA and RNA/mRNA platform delivery technologies. Scientifically trained at UC Davis, UC San Diego, and at the Salk Institute Molecular Biology and Virology laboratories, Dr. Malone received his medical training at Northwestern University (MD) and Harvard University Medical School (clinical research postgraduate fellowship), and in Pathology at UC Davis. He has almost one hundred academic peer-reviewed publications and has been an invited speaker or chair at about a hundred conferences. He is the author of Lies My Gov’t Told Me. Dr. Malone cofounded the Malone Institute, which aims to bring back integrity to government, the biological sciences, and medicine.
Experts Name 4 Reasons Splitting MMR Vaccine Makes Sense Zachary Stieber reports on Sept. 2, 2026, that some physicians support standalone measles, mumps, and rubella shots after President Trump’s August executive order on spacing childhood vaccines, including splitting MMR across visits, while Merck and GlaxoSmithKline defend the combination as safe and effective and the American Academy of Pediatrics says splitting is unnecessary. Neurologist Dr. Michael Segal said simultaneous live-virus components raise peak inflammation and that some post-vaccine seizures and neurological problems involve SCN1A variants, citing 2007 research, and that encephalitis is listed on the federal vaccine injury table with large court awards. He said he would prefer three separate shots for his own children. A White House spokesman told the paper splitting would give parents more timing options and could raise uptake of all three antigens as rates have fallen since 2020. Dr. Monique Yohanan of the Independent Women’s Forum said school closures and lost trust left many parents out of vaccination and that one antigen at a time might bring some back. Separate products existed until manufacturers focused on MMR in the 2000s to cut delays, Merck wrote in 2009. CDC advises MMR at 12–15 months and 4–6 years. Yohanan’s white paper, which she said circulated in the administration, puts ideal first measles at 15 months, possible standalone mumps at age 3, and rubella later in adolescence, and argues fewer shots per visit, versus as many as six now, would help isolate adverse events such as febrile seizure and anaphylaxis. Segal said MMR has no aluminum adjuvant unlike DTaP, so splitting it is easier. Merck has said separate products could take up to 10 years including trials. Segal suggested FDA might approve similar formulations without full new trials, as with updated COVID and flu shots. Dr. Robert Malone said combination immunity can wane and that splitting could yield better measles vaccines or mRNA alternatives, which would need to address reactogenicity seen in Moderna’s recently approved mRNA flu trial. FDA did not comment.
Perrigo Pulls Kids’ ‘Firefly’ Fluoride Mouthwash After Parents Sue Brenda Baletti, Ph.D., reports on Sept. 2, 2026, that parents dropped a class action against Perrigo after the company said in a dismissal notice it would stop commercializing FireFly Anticavity Mouth Rinse beyond a phase-out. The suit was one of six last year accusing dental brands of marketing fluoride products to toddlers with candy and fruit flavors and cartoon packaging that children treat as food, leading parents to use more than recommended and exposing kids to acute flu-like toxicity, dental fluorosis, neurotoxicity, and endocrine disruption. Firefly bottles featured Paw Patrol and Buzz Lightyear, shows aimed at ages 2–5, and parent reviews described children 1–3 eager to use bubble-gum rinse because of the characters. Perrigo denied toy-like design intended for young children. The rinse is gone from Amazon, with Walmart stock not to be replenished. About nine months earlier, Texas Attorney General Ken Paxton’s case pushed Procter & Gamble to change Crest ads for children under 6 starting January 2026 so amounts match CDC, ADA, and AAP guidance of a smear under age 3 and a pea-sized amount at 3–6, after ads showed full strips. A 2024 Nature study found parents overload brushes six to seven times the recommended amount. Paxton investigated Colgate and Crest in May 2025 and settled with Colgate-Palmolive in September 2025. In October 2025 FDA restricted unapproved prescription fluoride supplements for children under 3 and low- or moderate-risk older children, products with 0.25–1 mg fluoride versus 0.1–0.25 mg in age-appropriate toothpaste, while lawsuits put excess toothpaste and rinse exposure at 0.5 to more than 1 mg a day. A January 2025 JAMA Pediatrics review linked early fluoride to lower IQ, FDA’s Marty Makary ordered CDER review, EPA promised expedited water-risk review while appealing a 2024 order later struck on a technicality, and some cities and two states dropped water fluoridation.
Nationwide fluoride shortage halts fluoridation in Lewiston-Auburn drinking water Allyson LaPierre reports for WGME that tens of thousands of Lewiston and Auburn, Maine, tap customers are no longer getting fluoride after more than 50 years of community fluoridation, because the water district ran out of fluorosilicic acid amid a worldwide shortage, not a local policy choice. Auburn Water and Sewer District Superintendent Michael Broadbent said a June shipment never arrived, there is no U.S. manufacturer so all product is imported, and Northeast vendors have none. EPA lists Israel among top exporters, and officials tie disrupted supply to Middle East conflict and a prolonged Strait of Hormuz blockade. The two cities serve about 40,000 water customers and have added fluoride since the 1970s. Maine DHHS says fluoridation at the recommended target is a safe, effective way to prevent tooth decay, and Maine CDC recommends 0.7 milligrams of fluoride per liter. Broadbent said the district understands concern about lost dental benefits and is directing residents to dentists and healthcare providers for supplements, that fluoride does not affect water safety or taste, and that bills will not change. Officials do not know when the next shipment will arrive or when dosing will resume. If the shortage lasts, Broadbent said the cities may have to consider alternatives that could take time and cost extra money.
Higher Levels of Pesticides Found in Baby Teeth of Children With Autism Beyond Pesticides, republished Sept. 2, 2026, by Children’s Health Defense, reports a Neurotoxicology and Teratology biomonitoring study that measured pesticides and plasticizers in shed baby teeth from children with and without autism, using teeth that record exposures from about 13–14 weeks in utero through early childhood rather than short-term blood or urine. Thirty-eight autism-case teeth from The Autism Tooth Fairy Project at The University of Texas Health Science Center at San Antonio were compared with 16 controls. Sixty compounds appeared in more than half of 38 participants, 57 of 60 were higher in cases, 19 of 60 were statistically significantly elevated, 39 of 60 are known developmental toxicants or endocrine disruptors, and 21 of 60 lack EPA developmental toxicity data. Authors said they investigated cumulative exposures and that children face chronic, repeated contact with a wider range of developmental toxicants than short-term studies show. On average more than 300 toxicants were detected per tooth, including 12 pesticide-formulation compounds and 37 dual pesticide-plasticizer chemicals, for 49 pesticidal compounds with detection from 50 to 100 percent. The article notes autism prevalence cited as 1 in 31 children and more than 5.4 million U.S. adults, genetic plus environmental causes, and prior links of prenatal organophosphates and other pesticides to autism and ADHD. It says infants face higher hazards from size, developing organs, floor play, hand-to-mouth behavior, and higher intake relative to weight, and cites other work on neurotoxic pollutants, glyphosate use of about 250 million pounds a year in the U.S., parental chemical intolerance, and gestational glyphosate associated with infant neurodevelopment that is more pronounced at 24 months.
AAP Releases RSV Prevention, COVID Vax Recommendations for Fall Jennifer Henderson reports on Sept. 2, 2026, that the American Academy of Pediatrics updated RSV prevention and COVID vaccine guidance as medical groups fill a gap after CDC’s Advisory Committee on Immunization Practices skipped March and June meetings amid a legal challenge, and after HHS Secretary Robert F. Kennedy Jr. reduced universally recommended childhood shots earlier this year, a change a federal court has so far blocked for pediatric recommendations. Based on a technical report, the AAP Committee on Infectious Diseases recommended monoclonal antibody nirsevimab (Beyfortus) or clesrovimab (Enflonsia) for all infants younger than 8 months born during or entering their first RSV season unless they have documented protection from maternal vaccination, and RSV immunization for high-risk children 8 to 19 months entering a second season, with nirsevimab the only product indicated for that second-season group. High-risk criteria were expanded to include birth before 32 weeks 0 days regardless of support needs, hemodynamically significant congenital heart disease, anatomic pulmonary abnormalities or neuromuscular disorders that raise severe RSV risk, and Down syndrome or other chromosomal differences with higher severe-disease risk. Sean O’Leary, MD, MPH, of the committee said the products work well to prevent RSV hospitalization. For COVID, the committee recommended the 2026-2027 vaccine for all infants and children 6 to 23 months without contraindications, two or more age-appropriate doses for moderately or severely immunocompromised children 6 months to 18 years depending on prior status, and a single dose for ages 2 to 18 who are at high risk of severe COVID, live in long-term care or congregate settings, have never been vaccinated, or have high-risk household contacts, plus offering a dose to lower-risk children 2 and older if parents want protection. Any age-appropriate available COVID vaccine may be used, preferably the latest, after FDA approved four 2026-2027 shots targeting last season’s dominant variant. AAP issued its own schedule covering 18 diseases and no longer endorses CDC’s. President Andrew Racine, MD, PhD, said pediatricians have long used AAP’s schedule independently of CDC in recent years. IDSA, ACOG, and AAFP have also issued fall respiratory-virus guidance.Remember Friends, The Power to Heal is Yours!
